Litcius/Paper detail

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Ferdinando D'Amico, Laurent Peyrin-Biroulet, Silvio Danese

2022New England Journal of Medicine59 citationsDOI

Abstract

International audience

Topics & Concepts

MedicineTofacitinibRheumatoid arthritisInternal medicineCancerOncologyBreast cancerMEDLINEDiseaseArthritisRisk assessmentRisk factorRheumatoid Arthritis Research and TherapiesViral Infections and Immunology ResearchMonoclonal and Polyclonal Antibodies Research
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis | Litcius